B2M and neoplasm: For example, Dierssen et al. showed that distinct mechanisms are responsible for HLA class I loss in different tumor subtypes; loss of HLA class 1 expression was associated with the loss of β2m in HNPCC tumors and with APM component defects in MSI-H tumors [42].